The event will bring together over 350 participants and around 100 speakers, including representatives from Big Pharma, international and local manufacturers, distributors, and leaders of key associations in the Eurasian region.
32% of the participants are top executives (C-level decision-makers). Additionally, the forum will host leaders and team members from GR, Market Access and Registration, Medical Affairs, Commercial, and Business Development departments.